Maestros Mediline Systems Ltd
Maestros is India's leading medical diagnostic equipment and services organizations, which focuses on empowering medical professionals and institutions, that treat cardiac, gynecology and critical care patients across the country.
- Market Cap ₹ Cr.
- Current Price ₹ 10.4
- High / Low ₹ /
- Stock P/E
- Book Value ₹ -91.1
- Dividend Yield 0.00 %
- ROCE -19.1 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -57.8% over past five years.
- Company has high debtors of 1,251 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|
33.81 | 29.23 | 30.05 | 41.78 | 42.40 | 21.75 | 7.02 | 4.23 | 0.56 | |
30.28 | 25.66 | 26.06 | 33.48 | 34.79 | 31.93 | 20.46 | 25.74 | 2.99 | |
Operating Profit | 3.53 | 3.57 | 3.99 | 8.30 | 7.61 | -10.18 | -13.44 | -21.51 | -2.43 |
OPM % | 10.44% | 12.21% | 13.28% | 19.87% | 17.95% | -46.80% | -191.45% | -508.51% | -433.93% |
0.27 | 0.59 | 0.94 | 0.80 | 0.23 | 0.76 | -0.88 | 0.04 | 0.14 | |
Interest | 1.59 | 1.84 | 2.39 | 2.95 | 4.04 | 5.38 | 0.37 | 0.03 | 0.02 |
Depreciation | 1.27 | 1.26 | 1.76 | 2.37 | 1.86 | 2.06 | 1.00 | 0.79 | 0.70 |
Profit before tax | 0.94 | 1.06 | 0.78 | 3.78 | 1.94 | -16.86 | -15.69 | -22.29 | -3.01 |
Tax % | 44.68% | 75.47% | 23.08% | 2.91% | -7.73% | -7.41% | 0.00% | 0.00% | 0.00% |
0.52 | 0.26 | 0.60 | 3.67 | 2.08 | -15.61 | -15.69 | -22.29 | -3.00 | |
EPS in Rs | 0.59 | 1.36 | 8.34 | 4.73 | -35.48 | -35.66 | -50.66 | -6.82 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -58% |
3 Years: | -70% |
TTM: | -87% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 22% |
TTM: | 87% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.55 | 4.42 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 |
Reserves | 30.89 | 30.77 | 31.23 | 34.97 | 13.15 | -2.56 | -18.39 | -41.46 | -44.46 |
4.39 | 7.79 | 7.50 | 11.72 | 38.96 | 49.68 | 51.06 | 54.10 | 54.37 | |
18.60 | 23.58 | 26.00 | 24.39 | 21.25 | 22.43 | 20.16 | 5.91 | 7.79 | |
Total Liabilities | 58.43 | 66.56 | 69.10 | 75.45 | 77.73 | 73.92 | 57.20 | 22.92 | 22.07 |
23.17 | 28.04 | 28.19 | 31.14 | 15.62 | 15.28 | 13.45 | 11.89 | 11.19 | |
CWIP | 0.18 | 0.36 | 0.00 | 0.00 | 7.40 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 3.89 | 0.31 | 0.31 | 0.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
31.19 | 37.85 | 40.60 | 43.50 | 54.71 | 58.64 | 43.75 | 11.03 | 10.88 | |
Total Assets | 58.43 | 66.56 | 69.10 | 75.45 | 77.73 | 73.92 | 57.20 | 22.92 | 22.07 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|
12.76 | 7.28 | 3.24 | 2.84 | -7.50 | -6.77 | -0.45 | -0.27 | 0.09 | |
-4.82 | -2.58 | -1.55 | -5.98 | -14.89 | 1.08 | 0.94 | -0.38 | 0.05 | |
-7.48 | 0.98 | -2.88 | 1.28 | 23.80 | 2.16 | -0.26 | -0.14 | 0.04 | |
Net Cash Flow | 0.46 | 5.68 | -1.19 | -1.86 | 1.41 | -3.53 | 0.22 | -0.79 | 0.18 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 151.89 | 138.36 | 152.19 | 127.11 | 214.18 | 393.03 | 1,302.46 | 225.21 | 1,251.43 |
Inventory Days | 159.11 | 235.55 | 273.09 | 240.68 | 262.43 | 241.17 | 66.54 | 40.16 | 69.30 |
Days Payable | 114.78 | 180.48 | 239.65 | 153.77 | 208.96 | 179.85 | 256.98 | 128.95 | 1,686.39 |
Cash Conversion Cycle | 196.22 | 193.42 | 185.64 | 214.03 | 267.65 | 454.35 | 1,112.02 | 136.43 | -365.66 |
Working Capital Days | 138.29 | 120.38 | 138.83 | 162.84 | 259.03 | 579.30 | 1,132.44 | 319.27 | 1,003.75 |
ROCE % | 7.00% | 7.37% | 14.32% | 11.12% | -21.27% | -32.62% | -82.37% | -19.11% |
Documents
Announcements
- Outcome of AGM 31 Mar 2017
- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 23 Oct 2016
- Shareholding for the Period Ended September 30, 2016 22 Oct 2016
- Outcome of Board Meeting 30 Sep 2016
- Shareholding for the Period Ended June 30, 2016 21 Jul 2016